BrainsWay Deep Transcranial Magnetic Stimulation is an FDA-cleared medical device that is clinically proven effective and safe for the treatment of patients with Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD).
Patients with severe symptoms don't always respond sufficiently to evidence-based psychological treatments
Patients often fail to respond sufficiently to antidepressant medications
Patients often discontinue medication due to debilitating side effects
Get More Information
Read how BrainsWay Deep TMS can be an excellent addition to your patients' treatment regimen for MDD & OCD to improve their wellbeing!
>1 in 3 depression patients achieved remission in a large scale double-blinded multicenter RCT, including those that had failed to achieve sufficient benefit from multiple medications and CBT. Learn more
>1 in 2 OCD patients achieved over a 20% reduction in symptoms in a large scale double-blinded multicenter RCT, including those that failed to achieve sufficient benefit from ERP or medication. Learn more
BrainsWay Deep TMS treatment for depression and OCD is a non-invasive, outpatient procedure. Sessions last approximately 20 minutes, no anesthesia is required, and patients are able to resume normal activities immediately after treatment.
Clinical trials that led to FDA-clearance demonstrated no systemic side effects, unlike antidepressants that have been shown in many cases to result in significant side effects, including nausea, insomnia, weight gain, fatigue, and even suicidal thoughts.
Deep TMS is not intended to replace evidence-based psychotherapy, but rather offers a strong complementary medical device treatment option for patients that do not respond sufficiently to cognitive behavioral therapy, such as exposure-and-response prevention, alone.
Patients and clinicians report that in their practice, the use of Deep TMS has enabled patient's symptoms to improve to a degree that makes them more capable of participating fully in CBT exercises.